WallStreetZenWallStreetZen

NASDAQ: IPA
Immunoprecise Antibodies Ltd Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for IPA

Based on 2 analysts offering 12 month price targets for Immunoprecise Antibodies Ltd.
Min Forecast
$5.00+300%
Avg Forecast
$7.00+460%
Max Forecast
$9.00+620%

Should I buy or sell IPA stock?

Based on 2 analysts offering ratings for Immunoprecise Antibodies Ltd.
Buy
Strong Buy
0 analysts 0%
Buy
2 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their IPA stock forecasts and price targets.

IPA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-15
lockedlocked$00.00+00.00%2024-03-15

1 of 1

Forecast return on equity

Is IPA forecast to generate an efficient return?

Forecast return on assets

Is IPA forecast to generate an efficient return on assets?

IPA revenue forecast

What is IPA's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$18.3M+3.27%
Avg 2 year Forecast
$22.0M+24.55%
Avg 3 year Forecast
$26.9M+51.99%
IPA's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

IPA revenue growth forecast

How is IPA forecast to perform vs Biotechnology companies and vs the US market?
Company
15.55%
Industry
37.64%
Market
10.1%
IPA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
IPA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

IPA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
IPA$1.25$7.00+460.00%Buy
ICU$0.44N/AN/A
EVGN$0.65N/AN/A
VYNE$2.35$5.75+144.68%Buy
CASI$2.43$12.00+393.83%Buy
View Top Biotech Stocks

Immunoprecise Antibodies Stock Forecast FAQ

Is Immunoprecise Antibodies Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: IPA) stock is to Buy IPA stock.

Out of 2 analysts, 0 (0%) are recommending IPA as a Strong Buy, 2 (100%) are recommending IPA as a Buy, 0 (0%) are recommending IPA as a Hold, 0 (0%) are recommending IPA as a Sell, and 0 (0%) are recommending IPA as a Strong Sell.

If you're new to stock investing, here's how to buy Immunoprecise Antibodies stock.

What is IPA's revenue growth forecast for 2024-2026?

(NASDAQ: IPA) Immunoprecise Antibodies's forecast annual revenue growth rate of 15.55% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.64%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.1%.

Immunoprecise Antibodies's revenue in 2024 is $17,411,764.On average, 1 Wall Street analysts forecast IPA's revenue for 2024 to be $480,253,495, with the lowest IPA revenue forecast at $480,253,495, and the highest IPA revenue forecast at $480,253,495. On average, 1 Wall Street analysts forecast IPA's revenue for 2025 to be $579,198,873, with the lowest IPA revenue forecast at $579,198,873, and the highest IPA revenue forecast at $579,198,873.

In 2026, IPA is forecast to generate $706,827,884 in revenue, with the lowest revenue forecast at $706,827,884 and the highest revenue forecast at $706,827,884.

What is IPA's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: IPA) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is IPA's Price Target?

According to 2 Wall Street analysts that have issued a 1 year IPA price target, the average IPA price target is $7.00, with the highest IPA stock price forecast at $9.00 and the lowest IPA stock price forecast at $5.00.

On average, Wall Street analysts predict that Immunoprecise Antibodies's share price could reach $7.00 by Mar 15, 2025. The average Immunoprecise Antibodies stock price prediction forecasts a potential upside of 460% from the current IPA share price of $1.25.

What is IPA's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: IPA) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.